Neuroimaging in cannabis use: a systematic review of the literature
Rocío Martín‐Santos, Ana B. Fagundo, José Alexandre S. Crippa, Zerrin Atakan, Sagnik Bhattacharyya, Paul Allen, Paolo Fusar‐poli, Stefan Borgwardt, Marc L. Seal, Geraldo F. Busatto, Philip Mcguire
Psychological Medicine July 23, 2009 DOI: 10.1017/s0033291709990729 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Population | Cannabis users and controls in neuroimaging studies |
| Topics | Cannabis CBD |
| Keywords | Positron emission tomography Resting State FMRI Functional neuroimaging Anterior cingulate cortex Functional imaging Cognition Diffusion MRI Effects of cannabis Magnetic resonance imaging Radiology |
| Citations | 207 |
| Key findings | Functional neuroimaging suggests modulation of global and prefrontal metabolism during rest and after THC/marijuana administration, but evidence for major structural brain changes from cannabis is minimal. |
Abstract
Background: We conducted a systematic review to assess the evidence for specific effects of cannabis on brain structure and function. The review focuses on the cognitive changes associated with acute and chronic use of the drug.
Method: We reviewed literature reporting neuroimaging studies of chronic or acute cannabis use published up until January 2009. The search was conducted using Medline, EMBASE, LILACS and PsycLIT indexing services using the following key words: cannabis, marijuana, delta-9-tetrahydrocannabinol, THC, cannabidiol, CBD, neuroimaging, brain imaging, computerized tomography, CT, magnetic resonance, MRI, single photon emission tomography, SPECT, functional magnetic resonance, fMRI, positron emission tomography, PET, diffusion tensor MRI, DTI-MRI, MRS and spectroscopy.
Results: Sixty-six studies were identified, of which 41 met the inclusion criteria. Thirty-three were functional (SPECT/PET/fMRI) and eight structural (volumetric/DTI) imaging studies. The high degree of heterogeneity across studies precluded a meta-analysis. The functional studies suggest that resting global and prefrontal blood flow are lower in cannabis users than in controls. The results from the activation studies using a cognitive task are inconsistent because of the heterogeneity of the methods used. Studies of acute administration of THC or marijuana report increased resting activity and activation of the frontal and anterior cingulate cortex during cognitive tasks. Only three of the structural imaging studies found differences between users and controls.
Conclusions: Functional neuroimaging studies suggest a modulation of global and prefrontal metabolism both during the resting state and after the administration of THC/marijuana cigarettes. Minimal evidence of major effects of cannabis on brain structure has been reported.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: CBD Unclear
Reviews neuroimaging studies of cannabis and reports inconsistent activation findings and minimal evidence of structural brain changes, with CBD mentioned only as a search term.
Synthesized
Comparable studies
Other systematic reviews and meta-analyses on cannabis, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Effects of cannabis use on outcomes of psychotic disorders: systematic review People with psychotic disorders, as examined in 13 longitudinal studies | 2008 | Systematic review | |
| The Impact of Cannabis Use on Cognitive Functioning in Patients With Schizophrenia: A Meta-analysis of Existing Findings and New Data in a First-Episode Sample Patients with established schizophrenia (meta-analysis: 572) and patients with... | 2010 | Meta-analysis and cross-sectional observational study | n = 700 |
| Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review | 2020 | Systematic review | |
| Human Laboratory Studies on Cannabinoids and Psychosis. Healthy human subjects and individuals with schizophrenia | 2016 | Systematic review | |
| Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties | 2020 | Systematic review |
Citations in the library
Cited by 35
- Effects of Cannabis on Impulsivity: A Systematic Review of Neuroimaging Findings Current Pharmaceutical Design May 10, 2014
- Neural Correlates of the Severity of Cocaine, Heroin, Alcohol, MDMA and Cannabis Use in Polysubstance Abusers: A Resting-PET Brain Metabolism Study PLoS One June 29, 2012
- Neuroimaging in moderate MDMA use: A systematic review Neuroscience & Biobehavioral Reviews December 30, 2015
- Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study The International Journal of Neuropsychopharmacology April 14, 2011
- Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers Psychological Medicine October 1, 2012
and 30 more in the library
Cites 23
- Causal association between cannabis and psychosis: examination of the evidence The British Journal of Psychiatry January 30, 2004
- Distinct Effects of Δ9-Tetrahydrocannabinol and Cannabidiol on Neural Activation During Emotional Processing Archives of General Psychiatry 2009
- The effect of cannabis on the brain: can it cause brain anomalies that lead to increased risk for schizophrenia? Current Opinion in Psychiatry March 1, 2008
- Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum. Neuropsychopharmacology February 2009
- Neural basis of Delta-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition. Biological Psychiatry December 1, 2008
and 18 more in the library